Eli Lilly (NYSE: LLY)
Eli Lilly Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Eli Lilly Company Info
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
News & Analysis
Which Stock Will Dominate the Weight Management Market Through 2030?
How to Invest in Mounjaro
How to Invest in Ozempic
3 Reasons to Buy Eli Lilly Stock Like There's No Tomorrow
How to Invest in GLP-1 Stocks
Members of Congress Are Pouring Millions Into These 7 Surprising Stocks
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
Eli Lilly Just Made Another Move to Dominate the Weight Loss Market: Should You Buy the Stock?
Valuation
Podcast Episodes
The State of Weight Loss Drugs
None
Nvidia, Apple, and Eli Lilly: Manufacturing the Future
The great buildout for AI and GLP-1 drugs continues.
Digging Into What Hershey and Eli Lilly Told Investors
None
Investors Like Certainty. Trump's Win Gave Them Some.
We're also talking about Super Micro, Nvidia, and weight loss.
Earnings Transcripts
Eli Lilly (LLY) Q4 2024 Earnings Call Transcript
LLY earnings call for the period ending December 31, 2024.
Eli Lilly (LLY) Q3 2024 Earnings Call Transcript
LLY earnings call for the period ending September 30, 2024.
Eli Lilly (LLY) Q2 2024 Earnings Call Transcript
LLY earnings call for the period ending June 30, 2024.
Eli Lilly (LLY) Q1 2024 Earnings Call Transcript
LLY earnings call for the period ending March 31, 2024.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.